| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4H8X3
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 178 | 180 | PF00675 | 0.550 |
| CLV_NRD_NRD_1 | 62 | 64 | PF00675 | 0.255 |
| CLV_PCSK_FUR_1 | 178 | 182 | PF00082 | 0.539 |
| CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.601 |
| CLV_PCSK_KEX2_1 | 62 | 64 | PF00082 | 0.256 |
| CLV_PCSK_PC1ET2_1 | 180 | 182 | PF00082 | 0.635 |
| CLV_PCSK_SKI1_1 | 185 | 189 | PF00082 | 0.573 |
| CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.248 |
| CLV_Separin_Metazoa | 98 | 102 | PF03568 | 0.380 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.582 |
| LIG_14-3-3_CanoR_1 | 134 | 143 | PF00244 | 0.480 |
| LIG_14-3-3_CanoR_1 | 151 | 159 | PF00244 | 0.382 |
| LIG_14-3-3_CanoR_1 | 62 | 68 | PF00244 | 0.556 |
| LIG_Clathr_ClatBox_1 | 45 | 49 | PF01394 | 0.446 |
| LIG_FHA_1 | 24 | 30 | PF00498 | 0.620 |
| LIG_FHA_1 | 40 | 46 | PF00498 | 0.521 |
| LIG_LIR_Gen_1 | 154 | 163 | PF02991 | 0.616 |
| LIG_LIR_Gen_1 | 49 | 60 | PF02991 | 0.530 |
| LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.407 |
| LIG_Pex14_2 | 124 | 128 | PF04695 | 0.530 |
| LIG_REV1ctd_RIR_1 | 122 | 131 | PF16727 | 0.488 |
| LIG_SH2_CRK | 52 | 56 | PF00017 | 0.443 |
| LIG_SH2_PTP2 | 112 | 115 | PF00017 | 0.380 |
| LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.435 |
| LIG_SH2_STAT5 | 117 | 120 | PF00017 | 0.435 |
| LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.435 |
| MOD_CK1_1 | 11 | 17 | PF00069 | 0.617 |
| MOD_CK1_1 | 138 | 144 | PF00069 | 0.629 |
| MOD_CK2_1 | 24 | 30 | PF00069 | 0.600 |
| MOD_CK2_1 | 75 | 81 | PF00069 | 0.459 |
| MOD_CK2_1 | 99 | 105 | PF00069 | 0.546 |
| MOD_GlcNHglycan | 137 | 140 | PF01048 | 0.594 |
| MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.526 |
| MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.578 |
| MOD_GlcNHglycan | 21 | 24 | PF01048 | 0.748 |
| MOD_GSK3_1 | 113 | 120 | PF00069 | 0.494 |
| MOD_GSK3_1 | 134 | 141 | PF00069 | 0.693 |
| MOD_GSK3_1 | 19 | 26 | PF00069 | 0.612 |
| MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.595 |
| MOD_NEK2_1 | 24 | 29 | PF00069 | 0.563 |
| MOD_NEK2_1 | 84 | 89 | PF00069 | 0.595 |
| MOD_PIKK_1 | 75 | 81 | PF00454 | 0.459 |
| MOD_PKA_1 | 185 | 191 | PF00069 | 0.463 |
| MOD_PKA_2 | 100 | 106 | PF00069 | 0.516 |
| MOD_Plk_1 | 19 | 25 | PF00069 | 0.526 |
| MOD_Plk_4 | 113 | 119 | PF00069 | 0.451 |
| TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.380 |
| TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.530 |
| TRG_ER_diArg_1 | 108 | 111 | PF00400 | 0.450 |
| TRG_ER_diArg_1 | 172 | 175 | PF00400 | 0.581 |
| TRG_ER_diArg_1 | 178 | 181 | PF00400 | 0.572 |
| TRG_ER_diArg_1 | 61 | 63 | PF00400 | 0.521 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HUV2 | Leptomonas seymouri | 47% | 75% |
| A0A1X0NSZ2 | Trypanosomatidae | 34% | 88% |
| A0A3S7WUC9 | Leishmania donovani | 74% | 96% |
| A0A422N3W3 | Trypanosoma rangeli | 36% | 73% |
| A4HX97 | Leishmania infantum | 75% | 96% |
| C9ZTX0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 95% |
| E9AQZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 97% |
| Q4QEG4 | Leishmania major | 73% | 100% |
| V5BH99 | Trypanosoma cruzi | 37% | 90% |